Linnae Shahbaz
Family · Escondido, CANPI 1427712215
Payments from drug & device makers
Across 349 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$1K
- Pfizer$715
- Janssen Scientific Affairs, LLC$639
- Johnson & Johnson$585
- Boehringer Ingelheim$523
- plus $2K from 18 others
What the payments were for
- Food & beverage$8,461100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 88 | $2,140 |
| AbbVie | 66 | $1,422 |
| Pfizer | 29 | $715 |
| Janssen Scientific Affairs, LLC | 8 | $639 |
| Johnson & Johnson | 33 | $585 |
| Boehringer Ingelheim | 13 | $523 |
| Mallinckrodt Hospital Products Inc. | 21 | $427 |
| Aurinia Pharma U.S., Inc. | 17 | $348 |
| Radius Health, Inc. | 14 | $314 |
| GSK | 10 | $243 |
| Lilly USA, LLC | 11 | $229 |
| UCB, Inc. | 7 | $209 |
| AstraZeneca(2 entities) | 7 | $158 |
| Sobi, Inc | 4 | $92 |
| Novartis | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 4 | $61 |
| Kyowa Kirin, Inc. | 3 | $58 |
| Oxford Immunotec USA Inc | 2 | $53 |
| Ultragenyx Pharmaceutical Inc. | 3 | $46 |
| Scilex Pharmaceuticals Inc. | 2 | $45 |
| Genentech USA, Inc. | 1 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,471 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $11,168 |
| Diclofenac Sodium | 19 | $6,183 |
| Hydroxychloroquine Sulfate | 28 | $2,866 |
| MethotrexateMethotrexate Sodium | 58 | $990 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $609 |
| Metformin Hcl | 16 | $232 |
| Alendronate Sodium | 24 | $204 |
| Prednisone | 35 | $200 |
| Omeprazole | 18 | $178 |
| Atorvastatin Calcium | 18 | $148 |
| Lisinopril | 22 | $128 |
| Meloxicam | 16 | $57 |
Paid to pharmacies, not to this prescriber.
Other family in Escondido
- Jenine StoneEscondido$231K
- Abraham VandiverEscondido$69K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.